Literature DB >> 6309757

Reaction of calcium-activated neutral protease (CANP) with an epoxysuccinyl derivative (E64c) and iodoacetic acid.

K Suzuki.   

Abstract

The reaction of calcium activated neutral protease (CANP) with an epoxysuccinyl derivative (E64c) and iodoacetic acid (IAA) was examined in the presence of Ca2+, which specifically accelerates the rate of inactivation by these inhibitors. 1. E64c and IAA (100-fold molar excess) each inactivated CANP within a few minutes at 0 degrees C. Upon inactivation, 1 mol of E64c or IAA was incorporated into CANP. The reaction of CANP with E64c or IAA was optimal at pH 7.5-8.0, where CANP shows the maximum enzyme activity. 2. CANP modified with E64c or IAA lost one of the 3 SH groups (class II SH groups) which were exposed at the surface by addition of Ca2+. No conformation change of CANP was observed as a result of the modifications. 3. Leupeptin inhibited the modifications. A total of 1 mol of E64c and IAA was incorporated into CANP by successive labeling of CANP with E64c and IAA. It was concluded from these results that E64c and IAA specifically react with the same class II SH group, which is regarded as the active site of CANP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309757     DOI: 10.1093/oxfordjournals.jbchem.a134264

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  High molecular weight kininogen is an inhibitor of platelet calpain.

Authors:  A H Schmaier; H Bradford; L D Silver; A Farber; C F Scott; D Schutsky; R W Colman
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

2.  A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity.

Authors:  S H Cui; F Tanabe; H Terunuma; Y Iwatani; H Nunoi; K Agematsu; A Komiyama; A Nomura; T Hara; T Onodera; T Iwata; M Ito
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Catalytic-site characteristics of the porcine calpain II 80 kDa/18 kDa heterodimer revealed by selective reaction of its essential thiol group with two-hydronic-state time-dependent inhibitors: evidence for a catalytic site Cys/His interactive system and an ionizing modulatory group.

Authors:  G W Mellor; S K Sreedharan; D Kowlessur; E W Thomas; K Brocklehurst
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

4.  MNDO study of the mechanism of the inhibition of cysteine proteinases by diazomethyl ketones.

Authors:  M Tarnowska; S Oldziej; A Liwo; P Kania; F Kasprzykowski; Z Grzonka
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

5.  Calpain inhibition by peptide epoxides.

Authors:  C Parkes; A A Kembhavi; A J Barrett
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

6.  Purification and characterization of calpain from human polymorphonuclear leukocytes.

Authors:  J L Legendre; H P Jones
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

Review 7.  Calpain chronicle--an enzyme family under multidisciplinary characterization.

Authors:  Hiroyuki Sorimachi; Shoji Hata; Yasuko Ono
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 8.  Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.

Authors:  Gregory Hook; J Steven Jacobsen; Kenneth Grabstein; Mark Kindy; Vivian Hook
Journal:  Front Neurol       Date:  2015-09-02       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.